Advertisement

Thromboangiitis Obliterans (Buerger's Disease)

  • Eric L. Matteson
  • John H. Stone

A form of vasculitis associated with a highly inflam-matory clot within the lumen as well as inflammation within the vascular wall. Associated with active cigarette smoking, typically moderate to heavy. Tends to involve medium-sized arteries and veins, with the most striking clinical pathology related to arterial disease. Digital ischemia in all four extremities is a hallmark of the disorder, with the involvement of some extremities more characteristic than others. Severe digital ischemia without the evidence of internal organ involvement. Angiography reveals segmental involvement of medium-sized arteries, with abrupt vascular cut-offs and corkscrew collaterals. The major vessel involvement occurs at the levels of the ankle and wrist, with major consequences to the distal extremities. Smoking cessation is the only therapy known to be effective for Buerger's disease.

Keywords

Smoking Cessation Giant Cell Arteritis Systemic Vasculitis Internal Organ Involvement Atherosclerotic Coronary Artery Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Buerger L. Thromboangiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 1908; 136:567–80CrossRefGoogle Scholar
  2. Combemale P, Consort T, Denis-Thelis L, et al Cannabis arteritis. Br J Dermatol 2005;152:166–9PubMedCrossRefGoogle Scholar
  3. Cooper LT, Henderson SS, Ballman K V, et al A prospective, case control study of tobacco dependence in thromboangiitis obliterans (thromboangiitis obliterans). Angiology 2006;57:73–8PubMedCrossRefGoogle Scholar
  4. Cooper LT, Tse PS, Mikhail MA, et al Long-term survival and amputation risk in thromboangiitis obliterans (thromboangiitis obliterans). J Am Coll Cardiol 2004;44:2410–11PubMedCrossRefGoogle Scholar
  5. Disdier P, Swiader L, Jouglard J, et al Arterite du cannabis versus mala-die de leo buerger. Discussion nosologique a propos de deux nou-veaux cas. Presse Med 1999;28:71–4PubMedGoogle Scholar
  6. Hill GL. A rational basis for management of patients with the Buerger syndrome. Br J Surg 1974;61:476–81PubMedCrossRefGoogle Scholar
  7. Hirai M, Shionoya S. Arterial obstruction of the upper limb in throm-boangiitis obliterans: its incidence and primary lesion. Br J Surg 1979;66:124–8PubMedCrossRefGoogle Scholar
  8. Horton BT. The outlook in thromboangiitis obliterans. JAMA 1938; 111:2184–9CrossRefGoogle Scholar
  9. Lie JT. Thromboangiitis obliterans (Buerger's disease) in women. Medicine (Baltimore) 1987;66:65–72Google Scholar
  10. O'Dell J, Linder R, Markin RS, Moore GF. Thromboangiitis obliterans (Buerger's disease) and smokeless tobacco. Arthritis Rheum 1987; 30(9):1054–6PubMedCrossRefGoogle Scholar
  11. Olin J. Thromboangiitis obliterans (Buerger's disease). N Eng J Med 2000;343:864–70CrossRefGoogle Scholar
  12. Puechal X, Fiessinger JN, Kahan A, et al Rheumatic manifestations in patients with Thromboangiitis obliterans (Buerger's disease). J Rheumatol 1999;26:1764–8PubMedGoogle Scholar
  13. Puechal X, Fiessinger JN. Thromboangiitis obliterans or Buerger's disease: challenges for the rheumatologist. Rheumatology 2007;46:192–9PubMedCrossRefGoogle Scholar
  14. Quenneville JG, Prat A, Gossard D. Subungual-splinter hemorrhage: an early sign of thromboangiitis obliterans. Angiology 1981;32:424–32PubMedCrossRefGoogle Scholar
  15. Sasaki S, Sakuma M, Yasuda K. Current status of thromboangiitis oblit-erans (Buerger's disease) in Japan. Int J Cardiol 2000;75 Suppl 1:S175–81PubMedCrossRefGoogle Scholar
  16. Sterne J, Ducastaing C. [Arteritis caused by Cannabis indica]. Arch Mal Coeur Vaiss 1960;53:143–7PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Eric L. Matteson
    • 2
  • John H. Stone
    • 1
  1. 1.Clinical RheumatologyMassachusetts General HospitalBoston
  2. 2.Division of RheumatologyMayo ClinicRochesterUSA

Personalised recommendations